FDA Clears Secukinumab (Cosentyx) for Plaque Psoriasis – Medscape

FDA Clears Secukinumab (Cosentyx) for Plaque PsoriasisMedscape"Plaque psoriasis can cause significant skin irritation and discomfort for patients, so it is important to have a variety of treatment options available to patients," Amy Egan, MD, deputy director of the Office of Drug Evaluation III in the FDA's …and more »

[monetize id=”1″]
[monetize id=”2″]

Eczema treatment

Health Canada approves psoriasis treatment discovered through Dal‑led research – Dal News

Dal NewsHealth Canada approves psoriasis treatment discovered through Dal‑led researchDal News“In people with psoriasis, their IL-17A protein levels are six times higher than in normal skin,” says Dr. Langley. “When IL-17A levels are too high, it signals more skin cells to grow. And too many skin cells cause thickened skin and plaque to develop.”

https://www.dpsw.org/psoriasis-pictures